Nielsen S - Search Results

1

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe.

Marshall AD, Cunningham EB, Nielsen S, Aghemo A, Alho H, Backmund M, Bruggmann P, Dalgard O, Seguin-Devaux C, Flisiak R, Foster GR, Gheorghe L, Goldberg D, Goulis I, Hickman M, Hoffmann P, Jancorienė L, Jarcuska P, Kåberg M, Kostrikis LG, Makara M, Maimets M, Marinho RT, Matičič M, Norris S, Ólafsson S, Øvrehus A, Pawlotsky JM, Pocock J, Robaeys G, Roncero C, Simonova M, Sperl J, Tait M, Tolmane I, Tomaselli S, van der Valk M, Vince A, Dore GJ, Lazarus JV, Grebely J; International Network on Hepatitis in Substance Users (INHSU). Marshall AD, et al. Among authors: nielsen s. Lancet Gastroenterol Hepatol. 2018 Feb;3(2):125-133. doi: 10.1016/S2468-1253(17)30284-4. Epub 2017 Oct 3. Lancet Gastroenterol Hepatol. 2018. PMID: 28986139

2

Access to highly active antiretroviral therapy (HAART) for women and children in the WHO European Region 2002-2006.

Stengaard AR, Lazarus JV, Donoghoe MC, Nielsen S, Matic S. Stengaard AR, et al. Among authors: nielsen s. AIDS Care. 2009 Jul;21(7):893-902. doi: 10.1080/09540120802537872. AIDS Care. 2009. PMID: 20024746

3

Hepatitis C prevalence in Denmark in 2016-An updated estimate using multiple national registers.

Nielsen S, Hansen JF, Hay G, Cowan S, Jepsen P, Omland LH, Krarup HB, Søholm J, Lazarus JV, Weis N, Øvrehus A, Christensen PB. Nielsen S, et al. PLoS One. 2020 Sep 3;15(9):e0238203. doi: 10.1371/journal.pone.0238203. eCollection 2020. PLoS One. 2020. PMID: 32881877 Free PMC article.

4

Test uptake and hepatitis C prevalence in 5483 Danish people in drug use treatment from 1996 to 2015: a registry-based cohort study.

Øvrehus A, Nielsen S, Hansen JF, Holm DK, Christensen P. Øvrehus A, et al. Among authors: nielsen s. Addiction. 2019 Mar;114(3):494-503. doi: 10.1111/add.14479. Epub 2018 Nov 25. Addiction. 2019. PMID: 30347471

5

Access to highly active antiretroviral therapy (HAART) in the WHO European Region 2003-2005.

Bollerup AR, Donoghoe MC, Lazarus JV, Nielsen S, Matic S. Bollerup AR, et al. Among authors: nielsen s. Scand J Public Health. 2008 Mar;36(2):183-9. doi: 10.1177/1403494807085191. Scand J Public Health. 2008. PMID: 18519283

6

Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHO European Region 2002-2004.

Donoghoe MC, Bollerup AR, Lazarus JV, Nielsen S, Matic S. Donoghoe MC, et al. Among authors: nielsen s. Int J Drug Policy. 2007 Aug;18(4):271-80. doi: 10.1016/j.drugpo.2007.02.010. Epub 2007 Jun 21. Int J Drug Policy. 2007. PMID: 17689375

7

Concordance between self-reported and measured HIV and hepatitis C virus infection status among people who inject drugs in Germany.

Nielsen S, Gassowski M, Wenz B, Bannert N, Bock CT, Kücherer C, Ross RS, Bremer V, Marcus U, Zimmermann R; DRUCK study group. Nielsen S, et al. Hepatol Med Policy. 2016 Sep 1;1:8. doi: 10.1186/s41124-016-0016-6. eCollection 2016. Hepatol Med Policy. 2016. PMID: 30288312 Free PMC article.

8

Developing and Piloting a Standardized European Protocol for Hepatitis C Prevalence Surveys in the General Population (2016-2019).

Sperle I, Nielsen S, Bremer V, Gassowski M, Brummer-Korvenkontio H, Bruni R, Ciccaglione AR, Kaneva E, Liitsola K, Naneva Z, Perchemlieva T, Spada E, Toikkanen SE, Amato-Gauci AJ, Duffell E, Zimmermann R. Sperle I, et al. Among authors: nielsen s. Front Public Health. 2021 May 28;9:568524. doi: 10.3389/fpubh.2021.568524. eCollection 2021. Front Public Health. 2021. PMID: 34123980 Free PMC article.

9

Increasing prevalence of chronic hepatitis B virus infection and low linkage to care in Denmark on 31 December 2016 - an update based on nationwide registers.

Bollerup S, Wessman M, Hansen JF, Nielsen S, Hay G, Cowan S, Krarup H, Omland L, Jepsen P, Weis N, Christensen PB. Bollerup S, et al. Among authors: nielsen s. Infect Dis (Lond). 2023 Jan;55(1):17-26. doi: 10.1080/23744235.2022.2125065. Epub 2022 Oct 11. Infect Dis (Lond). 2023. PMID: 36221255

10

A large proportion of people who inject drugs are susceptible to hepatitis B: Results from a bio-behavioural study in eight German cities.

Haussig JM, Nielsen S, Gassowski M, Bremer V, Marcus U, Wenz B, Bannert N, Bock CT, Zimmermann R; DRUCK study group. Haussig JM, et al. Among authors: nielsen s. Int J Infect Dis. 2018 Jan;66:5-13. doi: 10.1016/j.ijid.2017.10.008. Epub 2017 Oct 31. Int J Infect Dis. 2018. PMID: 29097248 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,459 results

Search Page